Have a look and listen to the presentation:
NATA accreditation is the final certification they need to launch in AUS and USA as
" BREASTEST® will be introduced initially as an adjunct to the current standard of care. "
Different story if they want to become SoC.
What's different to others?
The high accuracy due to AI supported blood analysis.
Unless Jayne Shaw is a Con-Artist like Elizabeth Anne Holmes, this company has a real chance to become theeee game changer.
GLTA
Ann: Company Presentation - Investor Insights, page-40
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $39.45M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.5¢ | $36.15K | 344.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11853 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 281328 | 3 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| BDX (ASX) Chart |